These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8121187)

  • 21. Treatment for head and neck cancer.
    FDA Consum; 2006; 40(3):7. PubMed ID: 16909488
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of chemotherapy in squamous cell cancer of the head and neck (author's transl)].
    Schröder M; von Heyden HW
    HNO; 1981 Jul; 29(7):225-39. PubMed ID: 7021487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chemotherapy of head and neck cancer.
    Carter SK
    Semin Oncol; 1977 Dec; 4(4):413-24. PubMed ID: 74095
    [No Abstract]   [Full Text] [Related]  

  • 24. New treatment for head and neck cancer.
    FDA Consum; 2007; 41(2):5. PubMed ID: 17590894
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in chemotherapy for head and neck cancer.
    Bhide SA; Nutting CM
    Oral Oncol; 2010 Jun; 46(6):436-8. PubMed ID: 20400360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head and neck cancer chemoprevention gets a shot in the arm.
    Khuri FR; Shin DM
    J Clin Oncol; 2008 Jan; 26(3):345-7. PubMed ID: 18202405
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral preneoplasia and chemoprevention of squamous cell carcinoma of the head and neck.
    Kucuk O
    Cancer Treat Res; 2003; 114():61-83. PubMed ID: 12619538
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy in recurrent heat and neck cancer.
    Simmonds WP
    Otolaryngol Clin North Am; 1974 Feb; 7(1):205-15. PubMed ID: 4130287
    [No Abstract]   [Full Text] [Related]  

  • 29. Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck.
    Livingston RB; Einhorn LH; Burgess MA; Gottlieb JA
    Cancer Treat Rep; 1976 Jan; 60(1):103-5. PubMed ID: 63330
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacotherapy for squamous-cell carcinoma of the head and neck.
    Papaspyrou G; Werner JA; Dietz A
    Expert Opin Pharmacother; 2011 Feb; 12(3):397-409. PubMed ID: 21254947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
    Kies MS
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of oral miltefosine in patients with squamous cell head and neck cancer.
    Verweij J; Gandia D; Planting AS; Stoter G; Armand JP
    Eur J Cancer; 1993; 29A(5):778-9. PubMed ID: 8471342
    [No Abstract]   [Full Text] [Related]  

  • 34. Cetuximab plus radiotherapy for head and neck cancer.
    Hartig F; Pechlaner C
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710909
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between environmental carcinogens and EGFR targeting anti-tumor agents in head and neck cancer.
    Chao TC
    J Chin Med Assoc; 2010 Sep; 73(9):457-8. PubMed ID: 20875617
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of cancer of the head and neck--a cocktail with your PORT?
    Saunders MI; Rojas AM
    N Engl J Med; 2004 May; 350(19):1997-9. PubMed ID: 15128901
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of advanced cancer by isolation perfusion.
    Strawitz JG; Wolferth CC; Howard JM; Grotzinger PJ
    Arch Surg; 1965 Oct; 91(4):678-83. PubMed ID: 5214174
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung.
    Cappelaere P; Guiochet N; Bastit P; Favre R; Vanderburg M; Goupil A; Chauvergne J; Thomas D; Van Glabbeke M; Armand JP
    Eur J Cancer; 1993; 29A(8):1216. PubMed ID: 8518037
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy.
    Shah MK; Engstrom PF; Catalano RB; Paul AR; Bellet RE; Creech RH
    Cancer Treat Rep; 1982 Mar; 66(3):557-8. PubMed ID: 7060043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.